A New Peroxisomal Disorder with Enlarged Peroxisomes and a Specific Deficiency of Acyl-CoA Oxidase (pseudo-neonatal Adrenoleukodystrophy)

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1988 Mar 1

PMID 2894756

Citations 88

Authors

B T Poll-The

F Roels

H Ogier

J Scotto

J Vamecq

R B Schutgens

R J Wanders

C W van Roermund

M J van Wijland

A W Schram

Affiliations

Soon will be listed here.

Abstract

In the present paper two siblings are presented with clinical manifestations very similar to those of patients affected by neonatal adrenoleukodystrophy. In contrast to neonatal adrenoleukodystrophy patients, hepatic peroxisomes in these siblings were enlarged in size and not decreased in number. Accumulation of very-long-chain fatty acids (VLCFA) was associated with an isolated deficiency of the fatty acyl-CoA oxidase, the enzyme that catalyzes the first step of the peroxisomal beta-oxidation. Plasma levels of di- and trihydroxy-coprostanoic acid, phytanic acid, and pipecolic acid were normal; furthermore, acyl-CoA:dihydroxyacetone phosphate acyltransferase activity in cultured fibroblasts was also found to be normal. The clinical, biochemical, and cytochemical features found in these two siblings are compared with those seen in two other disorders characterized by the absence of a decreased number of hepatic peroxisomes and the presence of VLCFA: (1) pseudo-Zellweger syndrome (deficiency of peroxisomal thiolase activity) and (2) X-linked childhood adrenoleukodystrophy (deficiency of activation of lignoceric acid). Review of the different biochemical defects possible in very-long-chain fatty-acid oxidation reveals different clinical pictures of varying severity, depending on the level at which the biochemical defect occurs.

Citing Articles

Impaired peroxisomal beta-oxidation in microglia triggers oxidative stress and impacts neurons and oligodendrocytes.

Tawbeh A, Gondcaille C, Saih F, Raas Q, Loichot D, Hamon Y Front Mol Neurosci. 2025; 18:1542938.

PMID: 39958993 PMC: 11826809. DOI: 10.3389/fnmol.2025.1542938.

Anti-neuroinflammatory effects of conjugated linoleic acid isomers, c9,t11 and t10,c12, on activated BV-2 microglial cells.

Porcedda C, Manca C, Carta G, Piras F, Banni S, Sogos V Front Cell Neurosci. 2024; 18:1442786.

PMID: 39398647 PMC: 11466893. DOI: 10.3389/fncel.2024.1442786.

Fatty Acid Metabolism in Peroxisomes and Related Disorders.

Morito K, Ali H, Kishino S, Tanaka T Adv Exp Med Biol. 2024; 1470:31-55.

PMID: 38811487 DOI: 10.1007/5584_2024_802.

Generation and characterization of a zebrafish gain-of-function Mitchell disease model.

Raas Q, Wood A, Stevenson T, Swartwood S, Liu S, Kannan R Front Pediatr. 2024; 12:1326886.

PMID: 38357503 PMC: 10864527. DOI: 10.3389/fped.2024.1326886.

Differential Gene Expression in Human Fibroblasts Simultaneously Exposed to Ionizing Radiation and Simulated Microgravity.

Malatesta P, Kyriakidis K, Hada M, Ikeda H, Takahashi A, Saganti P Biomolecules. 2024; 14(1).

PMID: 38254688 PMC: 10812944. DOI: 10.3390/biom14010088.

References

Schutgens R, Schrakamp G, Wanders R, Heymans H, Moser H, Moser A . The cerebro-hepato-renal (Zellweger) syndrome: prenatal detection based on impaired biosynthesis of plasmalogens. Prenat Diagn. 1985; 5(5):337-44. DOI: 10.1002/pd.1970050506. View

Tager J, Van der Beek W, Wanders R, Hashimoto T, Heymans H, van den Bosch H . Peroxisomal beta-oxidation enzyme proteins in the Zellweger syndrome. Biochem Biophys Res Commun. 1985; 126(3):1269-75. DOI: 10.1016/0006-291x(85)90322-5. View

Hashmi M, Stanley W, Singh I . Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy. FEBS Lett. 1986; 196(2):247-50. DOI: 10.1016/0014-5793(86)80256-3. View

Wanders R, Saelman D, Heymans H, Schutgens R, Westerveld A, Poll-The B . Genetic relation between the Zellweger syndrome, infantile Refsum's disease, and rhizomelic chondrodysplasia punctata. N Engl J Med. 1986; 314(12):787-8. DOI: 10.1056/NEJM198603203141216. View

Schutgens R, Heymans H, Wanders R, van den Bosch H, Tager J . Peroxisomal disorders: a newly recognised group of genetic diseases. Eur J Pediatr. 1986; 144(5):430-40. DOI: 10.1007/BF00441734. View

Aubourg P, Scotto J, Rocchiccioli F, Robain O . Neonatal adrenoleukodystrophy. J Neurol Neurosurg Psychiatry. 1986; 49(1):77-86. PMC: 1028652. DOI: 10.1136/jnnp.49.1.77. View

Kelley R, Datta N, Dobyns W, HAJRA A, Moser A, Noetzel M . Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. Am J Med Genet. 1986; 23(4):869-901. DOI: 10.1002/ajmg.1320230404. View

Poll-The B, Saudubray J, Ogier H, Schutgens R, Wanders R, Schrakamp G . Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis. 1986; 9(2):169-74. DOI: 10.1007/BF01799455. View

Wanders R, van Roermund C, De Vries C, van den Bosch H, Schrakamp G, Tager J . Peroxisomal beta-oxidation of palmitoyl-CoA in human liver homogenates and its deficiency in the cerebro-hepato-renal (Zellweger) syndrome. Clin Chim Acta. 1986; 159(1):1-10. DOI: 10.1016/0009-8981(86)90160-9. View

10.

Roels F, Cornelis A, Poll-The B, Aubourg P, Ogier H, Scotto J . Hepatic peroxisomes are deficient in infantile refsum disease: a cytochemical study of 4 cases. Am J Med Genet. 1986; 25(2):257-71. DOI: 10.1002/ajmg.1320250210. View

11.

Poulos A, van Crugten C, Sharp P, Carey W, Robertson E, BECROFT D . Prenatal diagnosis of Zellweger syndrome and related disorders: impaired degradation of phytanic acid. Eur J Pediatr. 1986; 145(6):507-10. DOI: 10.1007/BF02429053. View

12.

Chen W, Watkins P, Osumi T, Hashimoto T, Moser H . Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy. Proc Natl Acad Sci U S A. 1987; 84(5):1425-8. PMC: 304443. DOI: 10.1073/pnas.84.5.1425. View

13.

Schram A, Goldfischer S, van Roermund C, Collins J, Hashimoto T, Heymans H . Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci U S A. 1987; 84(8):2494-6. PMC: 304678. DOI: 10.1073/pnas.84.8.2494. View

14.

Wanders R, van Roermund C, van Wijland M, Heikoop J, Schutgens R, Schram A . Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders. Clin Chim Acta. 1987; 166(2-3):255-63. DOI: 10.1016/0009-8981(87)90428-1. View

15.

Poll-The B, Saudubray J, Ogier H, Odievre M, Scotto J, Monnens L . Infantile Refsum disease: an inherited peroxisomal disorder. Comparison with Zellweger syndrome and neonatal adrenoleukodystrophy. Eur J Pediatr. 1987; 146(5):477-83. DOI: 10.1007/BF00441598. View

16.

Cooper A, Hatton C, Sardharwalla I . Acid beta-mannosidase of human plasma: influence of age and sex on enzyme activity. J Inherit Metab Dis. 1987; 10(3):229-33. DOI: 10.1007/BF01800067. View

17.

Wolff J, Nyhan W, Powell H, Takahashi D, HUTZLER J, HAJRA A . Myopathy in an infant with a fatal peroxisomal disorder. Pediatr Neurol. 1986; 2(3):141-6. DOI: 10.1016/0887-8994(86)90004-4. View

18.

Goldfischer S, Moore C, Johnson A, SPIRO A, VALSAMIS M, Wisniewski H . Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science. 1973; 182(4107):62-4. DOI: 10.1126/science.182.4107.62. View

19.

Roels F, Goldfischer S . Cytochemistry of human catalase. The demonstration of hepatic and renal peroxisomes by a high temperature procedure. J Histochem Cytochem. 1979; 27(11):1471-7. DOI: 10.1177/27.11.92501. View

20.

Osmundsen H, Neat C, Borrebaek B . Fatty acid products of peroxisomal beta-oxidation. Int J Biochem. 1980; 12(4):625-30. DOI: 10.1016/0020-711x(80)90015-4. View